Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic ...

Tel Aviv University researchers say neutrophils can be late-stage breast cancer target and biomarker; Beilinson Hospital ...

For patients with metastatic HR+/HER2— breast cancer, there were various trials to have come out of ASCO 2025 that are worth keeping your eye on.

Envision this possible future clinical scenario: a breast cancer patient and her physicians are deciding on the best possible ...

Novartis Canada is pleased to announce that Health Canada has granted a Notice of Compliance (NOC) for KISQALI® (ribociclib ...

Veteran actor Aruna Irani has finally revealed how she fought breast cancer twice and admitted that ignoring her doctor’s ...

Emerging research continues to spotlight the potential role of diet in cancer prevention, with olive oil—a cornerstone of the Mediterranean diet&mdas | Drug Discovery And Development ...